These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9498941)

  • 21. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
    Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP; Lundback B; Yigla M; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.
    Goldberg J; Böhning W; Schmidt P; Freund E
    Respir Med; 2000 Oct; 94(10):948-53. PubMed ID: 11059947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
    Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L
    J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
    Kleerup EC; Tashkin DP; Cline AC; Ekholm BP
    Chest; 1996 Mar; 109(3):702-7. PubMed ID: 8617079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
    Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
    Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
    Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH
    Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.
    Condemi JJ
    Clin Ther; 2001 Sep; 23(9):1529-41. PubMed ID: 11589265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
    Busse WW; Brazinsky S; Jacobson K; Stricker W; Schmitt K; Vanden Burgt J; Donnell D; Hannon S; Colice GL
    J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
    Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
    Boulet LP; Cartier A; Ernst P; Larivée P; Laviolette M
    Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.